Hester Biosciences Financials
NSE: HESTERBIO | BSE: 524669
₹2,308.90
₹-56.50
(-2.39%)
As on 09-Nov-2026IST
Market cap
₹1,949 Cr
Revenue (TTM)
₹353 Cr
P/E Ratio
13.7
P/B Ratio
4.2
Div. Yield
0.5 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
352.68
|
332.60
|
311.10
|
304.55
|
266.09
|
235.01
|
|
|
|
|
|
|
Total Income
|
353.50
|
347.01
|
315.03
|
315.67
|
281.45
|
248.75
|
|
|
|
|
|
|
Total Expenditure
|
245.12
|
250.66
|
250.05
|
251.38
|
215.69
|
175.02
|
|
|
|
|
|
|
EBITDA
|
107.56
|
81.94
|
61.05
|
53.17
|
50.40
|
59.98
|
|
|
|
|
|
|
Depreciation
|
24.47
|
18.88
|
16.80
|
17.17
|
20.70
|
16.58
|
|
|
|
|
|
|
EBIT
|
83.10
|
63.06
|
44.25
|
35.99
|
29.71
|
43.40
|
|
|
|
|
|
|
Interest
|
12.98
|
10.93
|
12.70
|
19.78
|
9.32
|
4.06
|
|
|
|
|
|
|
Other Income
|
0.82
|
14.41
|
3.92
|
11.13
|
15.36
|
13.74
|
|
|
|
|
|
|
Exceptional Items
|
88.70
|
2.94
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
159.64
|
75.84
|
39.57
|
31.95
|
40.15
|
53.50
|
|
|
|
|
|
|
Provision for Tax
|
23.53
|
18.35
|
10.75
|
10.79
|
12.12
|
14.02
|
|
|
|
|
|
|
Profit after Tax
|
136.11
|
57.48
|
28.83
|
21.17
|
28.04
|
39.48
|
|
|
|
|
|
|
Minority Interest
|
-1.13
|
-1.85
|
-1.34
|
-2.28
|
-1.41
|
-0.16
|
|
|
|
|
|
|
Share of Associate
|
7.11
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
142.09
|
55.64
|
27.49
|
18.89
|
26.63
|
39.32
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
467.78
|
360.24
|
314.26
|
291.79
|
279.73
|
259.99
|
|
|
|
|
|
|
Minority Interest
|
-1.13
|
7.55
|
12.40
|
11.08
|
8.82
|
7.41
|
|
|
|
|
|
|
Non-Current Liabilities
|
109.01
|
157.67
|
201.55
|
254.00
|
232.72
|
197.87
|
|
|
|
|
|
|
Current Liabilities
|
98.90
|
152.48
|
125.18
|
105.47
|
148.70
|
96.90
|
|
|
|
|
|
|
Total Liabilities
|
683.26
|
677.94
|
653.39
|
662.35
|
669.97
|
562.16
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
453.07
|
469.38
|
458.21
|
447.73
|
442.37
|
367.40
|
|
|
|
|
|
|
Current Assets
|
221.80
|
208.56
|
195.17
|
214.62
|
227.59
|
194.76
|
|
|
|
|
|
|
Total Assets
|
683.26
|
677.94
|
653.39
|
662.35
|
669.97
|
562.16
|
|
|
|
|
|
|
Total Debt*
|
--
|
188.26
|
207.78
|
239.04
|
268.15
|
222.57
|
|
|
|
|
|
|
Net Current Assets
|
122.90
|
56.08
|
69.99
|
109.14
|
78.90
|
97.87
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
--
|
--
|
--
|
0.20
|
0.15
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
64.14
|
64.51
|
48.18
|
23.60
|
8.71
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-2.87
|
-19.00
|
-22.61
|
-77.00
|
-116.59
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-48.79
|
-51.72
|
-26.09
|
41.76
|
111.54
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
12.48
|
-6.21
|
-0.52
|
-11.65
|
3.66
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
66.60
|
65.40
|
32.31
|
22.20
|
31.30
|
46.22
|
|
|
|
|
|
|
Cash EPS (₹)
|
167.03
|
89.77
|
53.64
|
45.07
|
57.28
|
65.90
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
549.88
|
423.46
|
369.41
|
343.00
|
328.82
|
305.61
|
|
|
|
|
|
|
Dividend per Share (₹)
|
0.48
|
11.00
|
7.00
|
6.00
|
8.00
|
10.00
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
75.40
|
75.83
|
56.64
|
27.74
|
10.24
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
32.20
|
41.12
|
20.71
|
-58.62
|
-92.19
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
16.21
|
9.93
|
9.59
|
9.60
|
14.12
|
|
|
|
|
|
|
ROE (%)
|
13.69
|
17.05
|
9.51
|
7.41
|
10.39
|
16.17
|
|
|
|
|
|
|
ROA (%)
|
20.04
|
8.64
|
4.38
|
3.18
|
4.55
|
8.11
|
|
|
|
|
|
|
EBIT Margin (%)
|
23.56
|
18.96
|
14.22
|
11.82
|
11.16
|
18.47
|
|
|
|
|
|
|
Net Margin (%)
|
38.50
|
16.57
|
9.15
|
6.71
|
9.96
|
15.87
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
22.95
|
14.66
|
12.58
|
18.18
|
23.67
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
17.48
|
6.91
|
2.15
|
14.45
|
13.23
|
9.65
|
|
|
|
|
|
|
EBIT Growth (%)
|
98.93
|
42.50
|
22.95
|
21.15
|
-31.55
|
-21.58
|
|
|
|
|
|
|
Net Profit Growth (%)
|
29.22
|
99.42
|
36.19
|
-24.50
|
-29.00
|
13.79
|
|
|
|
|
|
|
EPS Growth (%)
|
224.09
|
102.41
|
45.52
|
-29.06
|
-32.28
|
14.20
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
14.63
|
7.70
|
4.31
|
7.59
|
13.87
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
13.72
|
19.31
|
38.81
|
62.57
|
48.58
|
58.75
|
|
|
|
|
|
|
Price / Book Value
|
4.17
|
2.98
|
3.39
|
4.05
|
4.62
|
8.88
|
|
|
|
|
|
|
Dividend Yield (%)
|
0.48
|
0.87
|
0.56
|
0.43
|
0.53
|
0.37
|
|
|
|
|
|
|
EV/EBITDA
|
18.67
|
13.04
|
19.50
|
21.86
|
23.52
|
34.01
|
|
|
|
|
|
|
Close Price (₹)
|
2,175.80
|
1,259.10
|
1,254.50
|
1,394.45
|
1,522.80
|
2,713.45
|
|
|
|
|
|
|
High Price (₹)
|
2,683.60
|
2,350.00
|
3,379.00
|
1,939.95
|
2,856.35
|
3,180.00
|
|
|
|
|
|
|
Low Price (₹)
|
1,239.30
|
1,239.30
|
1,242.95
|
1,292.85
|
1,404.55
|
1,886.00
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
1,949.01
|
1,074.13
|
1,066.71
|
1,181.82
|
1,293.44
|
2,309.91
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.09
|
0.52
|
0.66
|
0.82
|
0.96
|
0.86
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.07
|
0.09
|
0.11
|
0.21
|
0.13
|
|
|
|
|
|
|
Current Ratio
|
2.24
|
1.37
|
1.56
|
2.03
|
1.53
|
2.01
|
|
|
|
|
|
|
Quick Ratio
|
1.45
|
0.89
|
1.00
|
1.32
|
0.96
|
1.23
|
|
|
|
|
|
|
Interest Coverage
|
13.30
|
7.94
|
4.12
|
2.62
|
5.31
|
14.16
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
23.16
|
28.67
|
23.52
|
25.82
|
29.93
|
23.52
|
|
|
|
|
|
|
Asset Turnover
|
0.52
|
0.50
|
0.47
|
0.46
|
0.44
|
0.49
|
|
|
|
|
|
|
Receivable days
|
--
|
92.43
|
89.02
|
94.77
|
91.87
|
80.50
|
|
|
|
|
|
|
Inventory Days
|
--
|
78.37
|
85.58
|
96.04
|
109.08
|
106.00
|
|
|
|
|
|
|
Payable days
|
--
|
120.46
|
114.21
|
106.28
|
113.04
|
129.73
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
50.33
|
60.38
|
84.54
|
87.91
|
56.77
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
